Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | GRN | P28799 | 2/20 | 0.38 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.38 |
| ▸ | LIPE | Q05469 | 6/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23228796 | 0.88 | LMNA (0.42) | LMNASCN9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL21656877 | 0.87 | HPGD (0.55) | ALDH1A1SMN1; SMN2HPGDMAPTPOLB | |
| SCHEMBL21657069 | 0.86 | LMNA (0.56) | LMNAALDH1A1MAPTGRNSORT1 | |
| SCHEMBL21628717 | 0.83 | LMNA (0.47) | LMNAALDH1A1SMN1; SMN2HPGDMAPT | |
| SCHEMBL21656657 | 0.82 | PTGER4 (0.35) | LMNASCN9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL21166757 | 0.79 | KDM4E (0.61) | LMNASCN9AALDH1A1HPGDMAPT | |
| SCHEMBL21656937 | 0.78 | SLC6A2 (0.45) | ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL21628386 | 0.77 | LMNA (0.63) | LMNAALDH1A1SMN1; SMN2HPGDLIPE | |
| SCHEMBL21628611 | 0.76 | ALDH1A1 (0.51) | LMNAALDH1A1SMN1; SMN2HPGDMAPT | |
| SCHEMBL21628517 | 0.75 | LMNA (0.54) | LMNAALDH1A1SMN1; SMN2HPGDLIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | LMNA 3083/4885SCN9A 4603/4885ALDH1A1 900/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | LMNA 3327/4885SCN9A 4485/4885ALDH1A1 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.